Daniel Jeremy 4/A
4/A · H-CYTE, INC. · Filed Apr 14, 2021
Insider Transaction Report
Form 4/AAmended
H-CYTE, INC.HCYT
Daniel Jeremy
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-01+5,000,000→ 5,000,000 totalExercise: $0.07Exp: 2031-04-01→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]This amendment is being filed to amend the vesting period for such options granted to Mr. Daniel on April 1, 2021. On April 1, 2021, Hy-Cyte, Inc. (the "Company) issued to Jeremy Daniel options (the "Options") to purchase 5,000,000 shares of the Company's common stock at an exercise price of $0.07. The Options shall be exercisable with respect to 1,000,000 Option Shares immediately upon the grant thereof, 1,250,000 shares shall be exercisable on the twelve (12) month anniversary of the Date of Grant, and the remaining Option Shares shall be exercisable in 6.25% quarterly installments for the remaining 3 year period, in each case, so long as Mr. Daniel remains an employee of the Company or a subsidiary thereof on each such date.